Biogen Inc.
BIIB
$210.73
-$1.77-0.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.03B | 9.94B | 9.89B | 10.07B | 10.00B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.03B | 9.94B | 9.89B | 10.07B | 10.00B |
| Cost of Revenue | 2.17B | 2.11B | 2.08B | 2.18B | 2.26B |
| Gross Profit | 7.85B | 7.82B | 7.81B | 7.89B | 7.74B |
| SG&A Expenses | 2.60B | 2.47B | 2.43B | 2.43B | 2.41B |
| Depreciation & Amortization | 572.60M | 531.80M | 507.10M | 486.10M | 460.50M |
| Other Operating Expenses | 300.10M | 306.30M | 290.20M | 277.40M | 259.50M |
| Total Operating Expenses | 7.52B | 7.21B | 7.06B | 7.14B | 7.24B |
| Operating Income | 2.50B | 2.73B | 2.83B | 2.92B | 2.76B |
| Income Before Tax | 1.01B | 1.62B | 1.56B | 1.90B | 1.80B |
| Income Tax Expenses | 176.80M | 251.10M | 263.60M | 295.50M | 267.20M |
| Earnings from Continuing Operations | 834.60 | 1.37K | 1.29K | 1.61K | 1.53K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 834.60M | 1.37B | 1.29B | 1.61B | 1.53B |
| EBIT | 2.50B | 2.73B | 2.83B | 2.92B | 2.76B |
| EBITDA | 3.35B | 3.53B | 3.61B | 3.69B | 3.50B |
| EPS Basic | 5.68 | 9.35 | 8.83 | 10.99 | 10.48 |
| Normalized Basic EPS | 9.99 | 11.01 | 11.53 | 11.85 | 11.05 |
| EPS Diluted | 5.65 | 9.32 | 8.81 | 10.96 | 10.45 |
| Normalized Diluted EPS | 9.94 | 10.98 | 11.50 | 11.82 | 11.02 |
| Average Basic Shares Outstanding | 588.20M | 587.00M | 585.90M | 584.90M | 584.00M |
| Average Diluted Shares Outstanding | 590.90M | 588.90M | 587.10M | 586.50M | 585.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |